Valuation: Precision System Science Co., Ltd.

Market Cap 532.74Cr 3.38Cr 2.98Cr 2.82Cr 2.56Cr 4.8Cr 324.19Cr 4.84Cr 34Cr 13Cr 165.55Cr 13Cr 12Cr P/E 2024
-4.68x
P/E 2025 -21.7x
Enterprise Value 485.54Cr 3.08Cr 2.72Cr 2.57Cr 2.33Cr 4.37Cr 295.47Cr 4.41Cr 31Cr 12Cr 150.88Cr 12Cr 11Cr EV / Sales 2024
1.18x
EV / Sales 2025 1.06x
Free-Float
75.87%
Yield 2024 *
-
Yield 2025 -
07/25/07 Tranche Update on Precision System Science Co., Ltd.'s Equity Buyback Plan announced on March 6, 2025. CI
07/25/07 Precision System Science Co., Ltd.'s Equity Buyback announced on March 6, 2025 has closed with 440,600 shares, representing 1.59% for ¥100.46 million. CI
06/25/06 Precision System Science Co., Ltd. announces an Equity Buyback for 440,600 shares, for ¥100.46 million. CI
06/25/06 Precision System Science Co., Ltd. authorizes a Buyback Plan. CI
01/25/01 Shuji Tajima completed the acquisition of Universal Bio Research Co., Ltd from Precision System Science Co., Ltd.. CI
14/24/14 Tajima agreed to acquire Universal Bio Research Co., Ltd from Precision System Science Co., Ltd. for ¥60 million. CI
18/23/18 Precision System Science Co., Ltd.(TSE:7707) dropped from S&P Global BMI Index CI
15/23/15 Precision System Science Co., Ltd. Reports Earnings Results for the Nine Months Ended March 31, 2023 CI
15/21/15 Tranche Update on Precision System Science Co., Ltd.'s Equity Buyback Plan announced on August 13, 2021. CI
15/21/15 Tranche Update on Precision System Science Co., Ltd.'s Equity Buyback Plan announced on August 13, 2021. CI
14/21/14 Precision System Science Co., Ltd.'s Equity Buyback announced on August 13, 2021 has expired with 152,100 shares for ¥99.97 million. CI
13/21/13 Precision System Science Co., Ltd. announces an Equity Buyback for 200,000 shares, representing 0.72% for ¥100 million. CI
13/21/13 Precision System Science Co., Ltd. authorizes a Buyback Plan. CI
1 day-0.96%
1 week-1.90%
Current month-6.36%
1 month-5.07%
3 months+10.16%
6 months-6.36%
Current year+10.75%
1 week 205
Extreme 205
212
1 month 201
Extreme 201
220
Current year 186
Extreme 186
299
1 year 175
Extreme 175
299
3 years 149
Extreme 149
595
5 years 149
Extreme 149
922
10 years 149
Extreme 149
3,150
Manager TitleAgeSince
President 40 01/09/2024
Corporate Officer/Principal 46 25/09/2026
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 55 30/09/2020
Director/Board Member 40 30/09/2024
Director/Board Member 46 30/09/2024
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%-1.90%-2.83%-36.02% 3.63Cr
+0.15%+3.17%+46.39%+35.11% 25TCr
-0.54%+4.76%+22.33%-8.53% 16TCr
-0.63%+2.62%-6.56%+39.18% 15TCr
-0.52%+0.37%-55.31%-17.78% 6.39TCr
+1.44%-0.29%+15.51%+25.90% 5TCr
-0.10%+8.08%+41.85%+56.28% 4.94TCr
-0.05%+1.79%-14.59%-19.95% 4.89TCr
+0.07%+4.56%+51.95%+60.98% 4.35TCr
+0.04%+13.89%+196.65%+105.52% 4.11TCr
Average -0.11%+2.72%+29.54%+24.07% 8.54TCr
Weighted average by Cap. -0.12%+2.72%+27.13%+25.91%

Financials

2024 2025
Net sales 397.9Cr 2.52Cr 2.23Cr 2.11Cr 1.91Cr 3.58Cr 242.14Cr 3.62Cr 25Cr 9.74Cr 123.65Cr 9.48Cr 9.27Cr 469.2Cr 2.98Cr 2.63Cr 2.48Cr 2.25Cr 4.22Cr 285.53Cr 4.27Cr 30Cr 11Cr 145.8Cr 11Cr 11Cr
Net income -112.1Cr -71.09L -62.74L -59.36L -53.83L -1.01Cr -68Cr -1.02Cr -7.12Cr -2.74Cr -35Cr -2.67Cr -2.61Cr -25Cr -16.04L -14.16L -13.4L -12.15L -22.78L -15Cr -23L -1.61Cr -61.94L -7.86Cr -60.25L -58.94L
Net Debt -55Cr -34.88L -30.78L -29.12L -26.41L -49.52L -33Cr -50.01L -3.49Cr -1.35Cr -17Cr -1.31Cr -1.28Cr -47Cr -29.93L -26.42L -24.99L -22.67L -42.5L -29Cr -42.92L -3Cr -1.16Cr -15Cr -1.12Cr -1.1Cr
Logo Precision System Science Co., Ltd.
Precision System Science Co., Ltd. is engaged in the development, manufacture and sales of various devices for lab (laboratory) automation and clinical diagnosis. The equipment business provides various automated equipment for lab such as deoxyribonucleic acid (DNA) automatic extractors and others, immunochemical luminescence measuring devices, specimen pretreatment devices for clinical diagnosis, and fully automated gene diagnostic equipment, among others. The reagents and consumables business provide various reagents used for DNA extraction and protein purification, as well as dedicated plastic consumables such as reaction vessel and others. The maintenance-related segment is engaged in equipment maintenance business, and the sales of spare parts (replacement parts). The contract manufacturing business is engaged in the contract manufacturing business.
Employees
151
Date Price Change Volume
29/26/29 JP¥206.00 -0.96% 33,500
28/26/28 JP¥208.00 -1.42% 62,900
25/26/25 JP¥211.00 0.00% 41,400

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7707 Stock